CLINICAL_TRIALS
trial_result
· 2013-05-24
Clinical Trial Update: Geodon for the Treatment of Refractory Social Anxiety Disorder [Phase 2]
Summary
Phase 2 trial of ziprasidone (Geodon) for refractory social anxiety disorder has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-05-24